Trial in progress: Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: Groningen International Study on Sentinel Nodes in Vulvar Cancer III (GROINSS-V III/NRG-GY024).

Authors

Lilian Tran Gien

Sunnybrook Odette Cancer Centre, Toronto, ON, Canada

Lilian Tran Gien , Brian M. Slomovitz , Mario M. Leitao Jr., Ate Van Der Zee , Carien L. Creutzberg , An K.L Reyners , Petronella Witteveen , Diandra Ayala-Peacock , Jyoti Mayadev , Charles A. Leath III, Maaike Oonk

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Sign-In

Similar Posters

insert_chart_outlined

Poster

2016 Genitourinary Cancers Symposium

bookmark_border

Long-term outcomes after bladder-preserving combined-modality therapy for patients with muscle-invasive bladder cancer.

First Author: Nicholas J Giacalone

insert_chart_outlined

Poster

2024 ASCO Genitourinary Cancers Symposium

bookmark_border

Preliminary efficacy and safety results from ReBirth: A phase II study of risk-based bladder-sparing therapy for MIBC.

First Author: Yijun Shen

insert_chart_outlined

Poster

2024 ASCO Gastrointestinal Cancers Symposium

bookmark_border

Ezabenlimab (BI 754091) plus modified docetaxel, cisplatin, and 5-fluorouracil (mDCF) followed by chemoradiotherapy (CRT) in patients (pts) with stage III squamous cell anal carcinoma (SCCA): Early efficacy endpoint results from the phase II INTERACT-ION study.

First Author: Stefano Kim

insert_chart_outlined

Poster

2024 ASCO Gastrointestinal Cancers Symposium

bookmark_border

Pembrolizumab, radiotherapy, and chemotherapy in neoadjuvant treatment of malignant esophago-gastric diseases (PROCEED): Assessment of survival and patterns of recurrence in a prospective, phase II single-arm trial.

First Author: Pooja Karukonda